Eli Lilly’s worst day in nearly 17 years: Strategist Jared Holz on Q1 results

Jared Holz, Mizuho Securities health care strategist, joins ‘Fast Money’ to discuss Eli Lilly’s biggest day drop since 2008 and the obesity drug competition.